Literature DB >> 15876335

Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?

S Papapetropoulos1, A Lieberman, J Gonzalez, D C Mash.   

Abstract

OBJECTIVES: Patients with clinical and pathological diagnosis of Parkinson's disease (PD) may, at death, also be found to have the pathological changes of Alzheimer's disease (AD). With this study we aim to determine the influence of AD pathology on the clinical phenotype of PD.
METHODS: We studied 64 patients who donated their brains to the University of Miami Brain Endowment Bank(TM) and fulfilled the clinical and pathological criteria for PD. For the evaluation of AD pathology we used the CERAD criteria. Dementia was diagnosed, in life, also using standard criteria. Case histories were abstracted and reviewed by one investigator (SP) who then made comparisons between patients.
RESULTS: Patients with AD pathology (PD-AD) were older both at the time of diagnosis and death. The presence of AD pathology did not seem to influence disease duration in our cohort of PD patients. As expected there was a clear relation between AD pathology and dementia but not all PD-AD patients were demented. Psychosis and depression were also found to be more prevalent in the PD-AD patients. In the comparison between demented and non-demented PD-AD patients dementia was more likely to appear in patients with PD and definite criteria for AD.
CONCLUSION: Apart from dementia AD pathology seems to be associated with a number of other clinical characteristics of PD.

Entities:  

Mesh:

Year:  2005        PMID: 15876335     DOI: 10.1111/j.1600-0404.2005.00411.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

Review 1.  Pathologic correlates of dementia in individuals with Lewy body disease.

Authors:  Joshua A Sonnen; Nadia Postupna; Eric B Larson; Paul K Crane; Shannon E Rose; Kathleen S Montine; James B Leverenz; Thomas J Montine
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

Review 2.  Cognitive impairment and dementia in patients with Parkinson disease.

Authors:  James B Leverenz; Joseph F Quinn; Cyrus Zabetian; Jing Zhang; Kathleen S Montine; Thomas J Montine
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

Review 3.  Mood, memory and movement: an age-related neurodegenerative complex?

Authors:  Ann-Charlotte Granholm; Heather Boger; Marina E Emborg
Journal:  Curr Aging Sci       Date:  2008-07

4.  Motor fluctuations and dyskinesias in advanced/end stage Parkinson's disease: a study from a population of brain donors.

Authors:  S Papapetropoulos; D C Mash
Journal:  J Neural Transm (Vienna)       Date:  2006-12-07       Impact factor: 3.575

5.  Presence of Striatal Amyloid Plaques in Parkinson's Disease Dementia Predicts Concomitant Alzheimer's Disease: Usefulness for Amyloid Imaging.

Authors:  Brittany N Dugger; Geidy E Serrano; Lucia I Sue; Douglas G Walker; Charles H Adler; Holly A Shill; Marwan N Sabbagh; John N Caviness; Jose Hidalgo; Megan Saxon-Labelle; Glenn Chiarolanza; Monica Mariner; Jonette Henry-Watson; Thomas G Beach
Journal:  J Parkinsons Dis       Date:  2012-01-01       Impact factor: 5.568

6.  Cerebral amyloid angiopathy in Lewy body disease.

Authors:  K A Jellinger; J Attems
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

7.  Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.

Authors:  Valeriy Duka; Jae-Hoon Lee; Joel Credle; Jonathan Wills; Adam Oaks; Ciaran Smolinsky; Ketul Shah; Deborah C Mash; Eliezer Masliah; Anita Sidhu
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

Review 8.  Cerebral correlates of psychotic syndromes in neurodegenerative diseases.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2012-05       Impact factor: 5.310

9.  The insertion/deletion polymorphism of the angiotensin converting enzyme (ACE) in Parkinson's disease.

Authors:  Spiridon Papapetropoulos; Kostantinos Glynos; Zongmin Zhou; Stylianos E Orfanos; Georgia Mitsi; Andreas Papapetropoulos
Journal:  Open Neurol J       Date:  2008-10-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.